Molecular Partners AG (MOLN)
NASDAQ: MOLN
· Real-Time Price · USD
3.64
-0.01 (-0.27%)
At close: Jun 05, 2025, 3:59 PM
3.56
-2.20%
After-hours: Jun 05, 2025, 04:04 PM EDT
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Switzerland Revenue | 4.97M | 7.04M | 179.9M |
| Switzerland Revenue Growth | -29.38% | -96.09% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.83M | 4.41M | 3.84M | 3.89M | 4.23M | 4.42M | 4.67M | 5.44M | 5.03M | 5.56M | 5.48M | 5.76M | 4.59M | 4.69M | 4.29M | 3.34M | 2.87M | 2.69M | 2.81M | 2.66M | 3.29M | 3.29M | 3.48M | 3.48M | 2.58M | 2.58M | 2.2M | 2.2M | 2.3M | 2.3M | 2.01M | 1.8M | 1.84M | 1.6M | 2.42M | 1.5M | 1.22M | 1.8M | 9.39M | 1.6M |
| Selling, General, and Administrative Revenue Growth | -13.16% | +14.83% | -1.29% | -8.07% | -4.41% | -5.21% | -14.28% | +8.32% | -9.62% | +1.46% | -4.81% | +25.45% | -2.11% | +9.40% | +28.14% | +16.48% | +6.77% | -4.14% | +5.37% | -19.15% | 0.00% | -5.39% | 0.00% | +34.91% | 0.00% | +17.17% | 0.00% | -4.30% | 0.00% | +14.68% | +11.44% | -2.23% | +15.06% | -33.88% | +61.33% | +23.36% | -32.44% | -80.83% | +486.76% | n/a |
| Research and Development Revenue | 10.55M | 10.86M | 13.09M | 14.1M | 12.85M | 11.61M | 11.63M | 12.7M | 12.21M | 11.5M | 12.57M | 14.47M | 12.46M | 11.68M | 15.42M | 16.16M | 18.17M | 12.77M | 11.78M | 13.36M | 12.25M | 12.25M | 9.5M | 9.5M | 10.24M | 10.24M | 8.86M | 8.86M | 9.26M | 9.26M | 10.94M | 8M | 8.38M | 8.7M | 10.64M | 7.5M | 7.32M | 5.9M | 7.2M | 4.6M |
| Research and Development Revenue Growth | -2.90% | -16.99% | -7.21% | +9.76% | +10.71% | -0.21% | -8.37% | +3.97% | +6.21% | -8.55% | -13.14% | +16.19% | +6.62% | -24.23% | -4.61% | -11.04% | +42.33% | +8.38% | -11.86% | +9.06% | 0.00% | +29.03% | 0.00% | -7.31% | 0.00% | +15.68% | 0.00% | -4.34% | 0.00% | -15.34% | +36.70% | -4.59% | -3.62% | -18.23% | +41.85% | +2.45% | +24.08% | -18.06% | +56.52% | n/a |